Single shot aims to stop liver cancer recurrence
Disease control
Recruiting now
This phase 2 trial tests whether a single injection of IP-001, given right after standard liver cancer ablation or surgery plus ablation, can help keep the cancer from coming back. About 126 adults with intermediate to high risk of recurrence will be followed for at least two yea…
Phase: PHASE2 • Sponsor: Robert C. Martin • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC